P53 acts as a co-repressor to regulate keratin 14 expression during epidermal cell differentiation

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Cai, Bi He ^a,c,e   Hsu, Pei Ching ^a,e   Hsin, I Lun ^a,f   Chao, Chung Faye ^a   Lu, Mei Hua ^a   Lin, Hwang Chi ^b   Chiou, Shih Hwa ^c   Tao, Pao Luh ^d   Chen, Jang Yi ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; PHORBOL 13 ACETATE 12 MYRISTATE; PIFITHRIN ALPHA; PROTEIN P160; PROTEIN P53; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA AFFINITY PRECIPITATION ASSAY; DOWN REGULATION; EPIDERMIS CELL; FEMALE; GENE MUTATION; GENETIC PROCEDURES; HUMAN; HUMAN CELL; KERATINOCYTE; OVARY TERATOMA; PREPUCE; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPRESSOR GENE; TUMOR CELL LINE; WILD TYPE;

BASE PAIRING; BASE SEQUENCE; BENZOTHIAZOLES; CELL DIFFERENTIATION; CELLS, CULTURED; CO-REPRESSOR PROTEINS; EPIDERMIS; FORESKIN; GENE EXPRESSION REGULATION; GENES, DOMINANT; HUMANS; KERATIN-14; KERATINOCYTES; MALE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84864199929     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041742     Document Type: Article

References (64)

1. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
2. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, et al. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11.
3. Westfall MD, Mays DJ, Sniezek JC, Pietenpol JA, (2003) The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol 23: 2264-2276.
4. Ichikawa T, Suenaga Y, Koda T, Ozaki T, Nakagawara A, (2008) TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation. Oncogene 27: 409-420.
5. Mangiulli M, Valletti A, Caratozzolo MF, Tullo A, Sbisa E, et al. (2009) Identification and functional characterization of two new transcriptional variants of the human p63 gene. Nucleic Acids Res 37: 6092-6104.
6. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713.
7. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718.
8. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, et al. (2001) p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98: 3156-3161.
9. Yang A, McKeon F, (2000) P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1: 199-207.
10. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316.
11. Eckert RL, Crish JF, Robinson NA, (1997) The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Phys Rev 77: 397-424.
12. Koster MI, Kim S, Huang J, Williams T, Roop DR, (2006) TAp63alpha induces AP-2gamma as an early event in epidermal morphogenesis. Dev Biol 289: 253-261.
13. Candi E, Rufini A, Terrinoni A, Dinsdale D, Ranalli M, et al. (2006) Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ 13: 1037-1047.
14. Romano RA, Ortt K, Birkaya B, Smalley K, Sinha S, (2009) An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS One 4: e5623.
15. Cai BH, Chao CF, Lu MH, Lin HC, Chen JY, (2012) A half-site of the p53 binding site on the keratin 14 promoter is specifically activated by p63. J Biochem doi:10.1093/jb/mvs053.
16. Lin HC, Shieh BH, Lu MH, Chen JY, Chang LT, et al. (2008) A method for quantifying melanosome transfer efficacy from melanocytes to keratinocytes in vitro. Pigment Cell Melanoma Res 21: 559-564.
17. Lu MH, Yang PC, Chang LT, Chao CF, (2000) Temporal and spatial sequence expression of cytokeratin K19 in cultured human keratinocyte. Proc Natl Sci Counc Repub China B 24: 169-177.
18. Jaken S, Yuspa SH, (1988) Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis 9: 1033-1038.
19. Pal S, Datta K, Mukhopadhyay D, (2001) Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res 61: 6952-6957.
20. Innocente SA, Lee JM, (2005) p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription. FEBS Lett 579: 1001-1007.
21. Farmer G, Friedlander P, Colgan J, Manley JL, Prives C, (1996) Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucleic Acids Res 24: 4281-4288.
22. Wu Y, Mehew JW, Heckman CA, Arcinas M, Boxer LM, (2001) Negative regulation of bcl-2 expression by p53 in hematopoietic cells. Oncogene 20: 240-251.
23. Koutsodontis G, Vasilaki E, Chou WC, Papakosta P, Kardassis D, (2005) Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis. Biochem J 389: 443-455.
24. Sauer M, Bretz AC, Beinoraviciute-Kellner R, Beitzinger M, Burek C, et al. (2008) C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity. Nucleic Acids Res 36: 1900-1912.
25. Cai BH, Chen JY, Lu MH, Chang LT, Lin HC, et al. (2009) Functional four-base A/T gap core sequence CATTAG of P53 response elements specifically bound tetrameric P53 differently than two-base A/T gap core sequence CATG bound both dimeric and tetrameric P53. Nucleic Acids Res 37: 1984-1990.
26. Herskowitz I, (1987) Functional inactivation of genes by dominant negative mutations. Nature 329: 219-222.
27. Milner J, Medcalf EA, (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65: 765-774.
28. Chan WM, Siu WY, Lau A, Poon RY, (2004) How many mutant p53 molecules are needed to inactivate a tetramer? Mol Cell Biol 24: 3536-3551.
29. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, et al. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737.
30. Paramio JM, Segrelles C, Lain S, Gomez-Casero E, Lane DP, et al. (2000) p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes. Mol Carcinog 29: 251-262.
31. Innocente SA, Lee JM, (2005) p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription. Biochem Biophys Res Commun 329: 713-718.
32. Beitzinger M, Oswald C, Beinoraviciute-Kellner R, Stiewe T, (2006) Regulation of telomerase activity by the p53 family member p73. Oncogene 25: 813-826.
33. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA, (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 20: 3185-3197.
34. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR, (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18: 126-131.
35. Sherman L, Itzhaki H, Jackman A, Chen JJ, Koval D, et al. (2002) Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. Virology 292: 309-320.
36. Yugawa T, Handa K, Narisawa-Saito M, Ohno S, Fujita M, et al. (2007) Regulation of Notch1 gene expression by p53 in epithelial cells. Mol Cell Biol 27: 3732-3742.
37. Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, et al. (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33: 416-421.
38. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, et al. (2006) Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev 20: 1028-1042.
39. Boehncke WH, Dahlke A, Zollner TM, Sterry W, (1994) Differential expression of heat shock protein 70 (HSP70) and heat shock cognate protein 70 (HSC70) in human epidermis. Arch Dermatol Res 287: 68-71.
40. Wu G, Osada M, Guo Z, Fomenkov A, Begum S, et al. (2005) DeltaNp63alpha up-regulates the Hsp70 gene in human cancer. Cancer Res 65: 758-766.
41. Agoff SN, Hou J, Linzer DI, Wu B, (1993) Regulation of the human hsp70 promoter by p53. Science 259: 84-87.
42. Lee KC, Crowe AJ, Barton MC, (1999) p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding. Mol Cell Biol 19: 1279-1288.
43. Banerjee T, Nath S, Roychoudhury S, (2009) DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling. Nucleic Acids Res 37: 2688-2698.
44. Mack DH, Vartikar J, Pipas JM, Laimins LA, (1993) Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363: 281-283.
45. Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, et al. (2005) Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 25: 3737-3751.
46. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
47. Li B, Lee MY, (2001) Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1. J Biol Chem 276: 29729-29739.
48. Sengupta S, Shimamoto A, Koshiji M, Pedeux R, Rusin M, et al. (2005) Tumor suppressor p53 represses transcription of RECQ4 helicase. Oncogene 24: 1738-1748.
49. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, et al. (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13: 2490-2501.
50. Ho J, Benchimol S, (2003) Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 10: 404-408.
51. Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, et al. (2006) Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene. Biochem J 400: 303-313.
52. Waterman MJ, Stavridi ES, Waterman JL, Halazonetis TD, (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 19: 175-178.
53. Rajagopalan S, Jaulent AM, Wells M, Veprintsev DB, Fersht AR, (2008) 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res 36: 5983-5991.
54. Rajagopalan S, Sade RS, Townsley FM, Fersht AR, (2010) Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms. Nucleic Acids Res 38: 893-906.
55. Bernerd F, Magnaldo T, Darmon M, (1992) Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 98: 902-910.
56. Baran W, Szepietowski JC, Szybejko-Machaj G, (2005) Expression of p53 protein in psoriasis. Acta Dermatovenerol Alp Panonica Adriat 14: 79-83.
57. Qin JZ, Chaturvedi V, Denning MF, Bacon P, Panella J, et al. (2002) Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene 21: 2991-3002.
58. Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, et al. (2003) Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes. Oncogene 22: 7607-7616.
59. Murphy PJ, Galigniana MD, Morishima Y, Harrell JM, Kwok RP, et al. (2004) Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation. J Biol Chem 279: 30195-30201.
60. Chua CC, Liu X, Gao J, Hamdy RC, Chua BH, (2006) Multiple actions of pifithrin-alpha on doxorubicin-induced apoptosis in rat myoblastic H9c2 cells. Am J Physiol Heart Circ Physiol 290: H2606-2613.
61. Codelia VA, Cisterna M, Alvarez AR, Moreno RD, (2010) p73 participates in male germ cells apoptosis induced by etoposide. Mol Hum Reprod 16: 734-742.
62. Sun R, Zhang Y, Lv Q, Liu B, Jin M, et al. (2011) Toll-like receptor 3 (TLR3) induces apoptosis via death receptors and mitochondria by up-regulating the transactivating p63 isoform alpha (TAP63alpha). J Biol Chem 286: 15918-15928.
63. Schavinsky-Khrapunsky Y, Huleihel M, Aboud M, Torgeman A, (2003) Role of protein kinase C and the Sp1-p53 complex in activation of p21(WAF-1) expression by 12-O-tetradecanoylphorbol-13-acetate in human T cells. Oncogene 22: 5315-5324.
64. Ou YH, Chung PH, Sun TP, Shieh SY, (2005) p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell 16: 1684-1695.